Evidence map›Paper›PMID 28235894›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.

Xu Wang, Lian Zhao, Yikui Zhang, Wenxin Ma, Shaimar R Gonzalez, Jianguo Fan, Friedrich Kretschmer, Tudor C Badea, Hao-Hua Qian, Wai T Wong

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. In the Eyes of the Beholder-NewInternational journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Retinal Toxicity Induced by Chemical Agents.International journal of molecular sciences · 2022
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Xu WangUnit on Neuron-Glia Interactions in Retinal Disease.
Lian ZhaoUnit on Neuron-Glia Interactions in Retinal Disease.ORCID 0000-0002-0120-1969
Yikui ZhangUnit on Neuron-Glia Interactions in Retinal Disease.ORCID 0000-0001-8607-8324
Wenxin MaUnit on Neuron-Glia Interactions in Retinal Disease.
Shaimar R GonzalezUnit on Neuron-Glia Interactions in Retinal Disease.
Jianguo FanSection on Molecular Structure and Functional Genomics.ORCID 0000-0003-1051-3283
Friedrich KretschmerRetinal Circuit Development and Genetics Unit, and.
Tudor C BadeaRetinal Circuit Development and Genetics Unit, and.
Hao-Hua QianVisual Function Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892.ORCID 0000-0002-1114-4697
Wai T WongUnit on Neuron-Glia Interactions in Retinal Disease, wongw@nei.nih.gov.ORCID 0000-0003-0681-4016
Associated Retinal Consultants · USHuman Computer Interaction (Switzerland) · CHJoint Center for Structural Genomics · USNational Institutes of Health · US

Funding

Functional Analysis of Novel Genes in Eye Development and VisionZIAEY000433 · NEI · NATIONAL EYE INSTITUTE · PI WISTOW, GRAEME J · 2009 to 2025
$18.2M
Retinal Circuit Development & GeneticsZIAEY000504 · NEI · NATIONAL EYE INSTITUTE · PI BADEA, TUDOR · 2011 to 2021
$15.6M
Visual Function CoreZICEY000503 · NEI · NATIONAL EYE INSTITUTE · PI QIAN, HAOHUA · 2011 to 2025
$12.3M
Role of Microglia in the Retina in Retinal DiseasesZIAEY000541 · NEI · NATIONAL EYE INSTITUTE · PI WONG, WAI · 2014 to 2020
$5.2M
Evaluation of Visual Function in Animal ModelsZIAEY000530 · NEI · NATIONAL EYE INSTITUTE · PI QIAN, HAOHUA · 2013 to 2025
$1.8M
6 · The paper itself

Abstract

Photoreceptor degeneration is a cause of irreversible vision loss in incurable blinding retinal diseases including retinitis pigmentosa (RP) and atrophic age-related macular degeneration. We found in two separate mouse models of photoreceptor degeneration that tamoxifen, a selective estrogen receptor modulator and a drug previously linked with retinal toxicity, paradoxically provided potent neuroprotective effects. In a light-induced degeneration model, tamoxifen prevented onset of photoreceptor apoptosis and atrophy and maintained near-normal levels of electroretinographic responses. Rescue effects were correlated with decreased microglial activation and inflammatory cytokine production in the retina

Indexed as

AnimalsApoptosisDose-Response Relationship, DrugFemaleMaleMiceMice, Inbred C57BLNerve RegenerationNeuroprotective AgentsPhotoreceptor Cells, VertebrateRecovery of FunctionRetinal DegenerationTamoxifenTreatment OutcomeNeuroprotective AgentsTamoxifendegenerationmicroglianeuroprotectionphotoreceptorretinitis pigmentosatamoxifen

Identifiers

PMID28235894
PMCPMC5373119
OpenAlexW2590974264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.